Literature DB >> 11216752

Induction of inflammatory mediators during reperfusion of the human heart.

G Valen1, G Paulsson, J Vaage.   

Abstract

BACKGROUND: Cardioplegia and reperfusion may induce an inflammatory reaction, which may contribute to postoperative morbidity and mortality.
METHODS: Gene expression of cytokines, adhesion molecules, and vasoactive substances was evaluated in left ventricular biopsies taken before cardioplegia (lasting approximately 70 minutes) and after reperfusion (approximately 40 minutes) from 19 patients (5 with valvular or combined disease, 7 with stable angina pectoris, 7 with unstable angina). mRNA was extracted and amplified with a semiquantitative reverse transcription polymerase chain reaction.
RESULTS: Cardioplegia-reperfusion increased mRNA for E-selectin by a factor of 17 +/- 5 (p < 0.002) (mean +/- SEM), interleukin-1beta, with 9 +/- 3 (p < 0.007), tumor necrosis factor-alpha with 6 +/- 3 (p < 0.05), interleukin-2 receptor alpha chain CD25 with 2 +/- 0.6 (p < 0.04), and intercellular adhesion molecule-1 with 2 +/- 0.4 (p < 0.005). Before cardioplegia, mRNA for endothelial nitric oxide synthase was predominantly detected in unstable angina patients, and increased by a factor of 11 +/- 6 (p < 0.02) during reperfusion. mRNA for endothelin-1 decreased by a factor of 0.5 +/- 0.1 (p < 0.0005). The changes were more pronounced in unstable patients. The transcription factor nuclear factor kappa B (NFkappaB), which regulates expression of inflammatory mediators, was activated during reperfusion (n = 10, p < 0.0001).
CONCLUSIONS: Open heart surgery induces an inflammatory response in the human heart, which is more pronounced in patients with unstable angina. It involves NFkappaB activation and expression of several NFkappaB-regulated genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11216752     DOI: 10.1016/s0003-4975(00)02146-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

Review 1.  [Cardiopulmonary bypass in cardiac surgery].

Authors:  T Baehner; O Boehm; C Probst; B Poetzsch; A Hoeft; G Baumgarten; P Knuefermann
Journal:  Anaesthesist       Date:  2012-10       Impact factor: 1.041

2.  Attenuated recovery of contractile function in aging hearts following global ischemia/reperfusion: Role of extracellular HSP27 and TLR4.

Authors:  Lihua Ao; Yufeng Zhai; Chunhua Jin; Joseph C Cleveland; David A Fullerton; Xianzhong Meng
Journal:  Mol Med       Date:  2016-12-19       Impact factor: 6.354

Review 3.  Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protection.

Authors:  Qin Yang; Guo-Wei He; Malcolm John Underwood; Cheuk-Man Yu
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  Micronized purified flavonoid fraction in pretreating CABG patients.

Authors:  Mustafa Sirlak; A Ruchan Akar; Sadik Eryilmaz; Elif Kuzgun Cetinkanat; Evren Ozcinar; Bulent Kaya; Atilla Halil Elhan; Umit Ozyurda
Journal:  Tex Heart Inst J       Date:  2010

5.  Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: mediating KC and MCP-1 expression induced by extracellular HSC70.

Authors:  Lihua Ao; Ning Zou; Joseph C Cleveland; David A Fullerton; Xianzhong Meng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-15       Impact factor: 4.733

6.  Human myocardium releases heat shock protein 27 (HSP27) after global ischemia: the proinflammatory effect of extracellular HSP27 through toll-like receptor (TLR)-2 and TLR4.

Authors:  Chunhua Jin; Joseph C Cleveland; Lihua Ao; Jilin Li; Qingchun Zeng; David A Fullerton; Xianzhong Meng
Journal:  Mol Med       Date:  2014-06-09       Impact factor: 6.354

7.  Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats.

Authors:  Wen Zhang; Yi Han; Guoliang Meng; Wenli Bai; Liping Xie; Hui Lu; Yongfeng Shao; Lei Wei; Shiyang Pan; Suming Zhou; Qi Chen; Albert Ferro; Yong Ji
Journal:  J Am Heart Assoc       Date:  2014-01-28       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.